Effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic Fatty Liver Disease (NAFLD) - Trial SLCTR_2015_023
Access comprehensive clinical trial information for SLCTR_2015_023 through Pure Global AI's free database. This Phase 2 trial is sponsored by Armed Forces Institute of Pathology, Pakistan and is currently Recruiting. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2015_023
Phase 2
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2015_023
Effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic Fatty Liver Disease (NAFLD)
A randomized controlled, double blinded, clinical trial investigating the effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic fatty liver disease
Study Focus
Interventional
Sponsor & Location
Armed Forces Institute of Pathology, Pakistan
Pakistan
Timeline & Enrollment
Phase 2
N/A
N/A
ICD-10 Classifications
Liver disease, unspecified
Inflammatory liver disease, unspecified
Alcoholic liver disease, unspecified
Alcoholic fatty liver
Toxic liver disease, unspecified
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2015_023
Non-Device Trial